LexisNexis® Legal Newsroom
Avastin Breast Cancer Approval Revoked By FDA After Little Benefit Shown

ROCKVILLE, Md. -- The Food and Drug Administration on Nov. 18 revoked approval for Avastin to treat breast cancer after concluding that the drug did not slow progression of tumors and that any benefits did not outweigh the drug's risks. ( Decision. Document #28-111201-001X .) In 2008, the...